How to buy Burning Rock Biotech stock - 19 April
finder.com

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Burning Rock Biotech stock

Own Burning Rock Biotech stock in just a few minutes.

Buy Burning Rock Biotech Limited (BNR)
Fact checked

Burning Rock Biotech Limited is a diagnostics & research business based in the US. Burning Rock Biotech shares (BNR) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Burning Rock Biotech

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Burning Rock Biotech. Find the stock by name or ticker symbol: BNR. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Burning Rock Biotech reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Burning Rock Biotech, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Burning Rock Biotech. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

What's in this guide?

  1. BNR shares summary
  2. Compare share dealing platforms
  3. Is BNR stock a buy or sell?
  4. Stock performance over time
  5. Can I short BNR shares?
  6. Burning Rock Biotech's financials
  7. Does Burning Rock Biotech pay a dividend?
  8. Have BNR shares ever split?
  9. Other common questions

Burning Rock Biotech share price

Use our graph to track the performance of BNR stocks over time.

Burning Rock Biotech shares at a glance

Information last updated 2021-03-26.
52-week rangeUSD$18.64 - USD$39.75
50-day moving average USD$31.55
200-day moving average USD$27.82
Wall St. target priceUSD$23.15
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.48

Buy Burning Rock Biotech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Go to site
More Info
Robinhood
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Go to site
More Info
Interactive Brokers
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Go to site
More Info
Webull
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Go to site
More Info
Public
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
Go to site
More Info
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Burning Rock Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Burning Rock Biotech Limited by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Burning Rock Biotech financials

Revenue TTM USD$66 million
Gross profit TTM USD$313.9 million
Return on assets TTM -14.68%
Return on equity TTM -26.44%
Profit margin -94.73%
Book value N/A
Market capitalisation USD$2.6 billion

TTM: trailing 12 months

Shorting Burning Rock Biotech shares

There are currently 935,234 Burning Rock Biotech shares held short by investors – that's known as Burning Rock Biotech's "short interest". This figure is 131.7% up from 403,558 last month.

There are a few different ways that this level of interest in shorting Burning Rock Biotech shares can be evaluated.

Burning Rock Biotech's "short interest ratio" (SIR)

Burning Rock Biotech's "short interest ratio" (SIR) is the quantity of Burning Rock Biotech shares currently shorted divided by the average quantity of Burning Rock Biotech shares traded daily (recently around 423182.80542986). Burning Rock Biotech's SIR currently stands at 2.21. In other words for every 100,000 Burning Rock Biotech shares traded daily on the market, roughly 2210 shares are currently held short.

However Burning Rock Biotech's short interest can also be evaluated against the total number of Burning Rock Biotech shares, or, against the total number of tradable Burning Rock Biotech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Burning Rock Biotech's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Burning Rock Biotech shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Burning Rock Biotech shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Burning Rock Biotech.

Find out more about how you can short Burning Rock Biotech stock.

Burning Rock Biotech share dividends

We're not expecting Burning Rock Biotech to pay a dividend over the next 12 months.

Have Burning Rock Biotech's shares ever split?

Burning Rock Biotech's shares were split on a 1:3 basis on 31 July 2014. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Burning Rock Biotech shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Burning Rock Biotech shares which in turn could have impacted Burning Rock Biotech's share price.

Burning Rock Biotech overview

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 13 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoScreen Plus that targets therapy and immunotherapy, as well as immunotherapy- related biomarkers, such as microsatellite instability and tumor mutation burden, and NTRK fusions; and LungPlasma, a circulating tumor DNA liquid biopsy- based test for non-small cell lung cancer. It also offers ColonCore for testing gastrointestinal cancers; and HRDCore for testing genes associated with homologous recombination deficiency. Burning Rock Biotech Limited has collaborations on clinical trials and research studies with major pharmaceutical companies, including AstraZeneca, Bayer, Johnson & Johnson, Sino Biopharm, CStone Pharmaceuticals, and BeiGene primarily through central laboratory and companion diagnostics development services to pharmaceutical companies. The company was founded in 2014 and is headquartered in Guangzhou, China. .

  1. Technical analysis graphic from TradingView, https://uk.tradingview.com/ Stock prices and other date from EOD Historical Data

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site